Parkinson's Disease Trial, Recruiting (NCT07360977)

Parkinson's Disease Trial, Recruiting NCT07360977 Sponsor: IRCCS Centro Neurolesi Bonino Pulejo Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07360977 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Parkinson's disease (PD):

You are between 45 and 75 years old
You have been formally diagnosed with Parkinson's disease using a recognised set of medical guidelines (UK Brain Bank Criteria)
Your condition has been stable for at least 3 months before joining the study
Your Parkinson's medications have not changed for at least 3 months before joining the study

For people with Multiple Sclerosis (MS):

You are 18 years old or older
You have been diagnosed with relapsing-remitting MS (a type of MS where symptoms come and go) using recognised medical guidelines (McDonald criteria)
Your level of disability, as measured by a standard scale, is at or below a moderate level (confirm with trial site)
Your condition has been stable for at least 30 days before joining the study
Your MS treatment has not changed for at least 3 months before joining the study

For all adult participants (PD and MS):

You are willing to keep your medications unchanged throughout the 6-month study period
You are able to understand what the study involves and complete the required tests and check-ups
You are willing to sign a form giving your informed consent to take part

For children:

Your condition is currently stable
You are between 1 and 10 years old and weigh between 5 and 30 kg
You are not currently taking part in any other clinical trial

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan
You have another neurological condition or serious health problem that could affect the study results, such as a spinal injury, cancer, dementia, stroke, epilepsy, or a psychiatric disorder
Your score on a standard memory and thinking test (called the MMSE) falls below a certain level (confirm with trial site)
You are currently taking part in another clinical trial
You are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emanuela Mazzon, IRCCS Centro Neurolesi Bonino Pulejo

Phone: 09060128163

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07360977

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 09060128163

More information: https://clinicaltrials.gov/study/NCT07360977

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with Parkinson's disease (PD):

You are between 45 and 75 years old
You have been formally diagnosed with Parkinson's disease using a recognised set of medical guidelines (UK Brain Bank Criteria)
Your condition has been stable for at least 3 months before joining the study
Your Parkinson's medications have not changed for at least 3 months before joining the study

For people with Multiple Sclerosis (MS):

You are 18 years old or older
You have been diagnosed with relapsing-remitting MS (a type of MS where symptoms come and go) using recognised medical guidelines (McDonald criteria)
Your level of disability, as measured by a standard scale, is at or below a moderate level (confirm with trial site)
Your condition has been stable for at least 30 days before joining the study
Your MS treatment has not changed for at least 3 months before joining the study

For all adult participants (PD and MS):

You are willing to keep your medications unchanged throughout the 6-month study period
You are able to understand what the study involves and complete the required tests and check-ups
You are willing to sign a form giving your informed consent to take part

For children:

Your condition is currently stable
You are between 1 and 10 years old and weigh between 5 and 30 kg
You are not currently taking part in any other clinical trial

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan
You have another neurological condition or serious health problem that could affect the study results, such as a spinal injury, cancer, dementia, stroke, epilepsy, or a psychiatric disorder
Your score on a standard memory and thinking test (called the MMSE) falls below a certain level (confirm with trial site)
You are currently taking part in another clinical trial
You are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Centro Neurolesi Bonino Pulejo

Registry

ClinicalTrials.gov

Start date

1 January 2026

Est. completion

19 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Unified Parkinson's Disease Rating Scale (UPDRS) Total Score; Hoehn and Yahr scale; Expanded Disability Status Scale (EDSS) for Multiple Sclerosis patients; Cognitive and Neuropsychological Assessments: Montreal Cognitive Assessment (MoCA) and Mini-mental state examination; Brief Repeatable Battery (BRB) of Neuropsychological Tests for Multiple Sclerosis patients; Normalized Brain Volume (NBV); Normalized Cortical Volume (NCV); Change from Baseline in Whole-Brain Fractional Anisotropy (FA) in Multiple Sclerosis Patients; Change from Baseline in Whole-Brain Mean Diffusivity (MD) in Multiple Scl...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov